Is BridgeBio Oncology Therapeutics a good buy right now?
USNASDAQ: BBOTNASDAQ-listedlast $10.75 · 5 Jan 2026
Not yet — wait
No open signal as of 30 Sep 2026. The last Buy signal came on 22 Sep 2025 at $11.23 and closed on 5 Jan 2026 (−4.2%).
As of 30 Sep 2026 · Firefly Breakout Weekly
What happened after the last 9 buy signals on BBOT
Oct 2024 – 30 Sep 20261 of 9 closed above the entry price, with an average outcome of −7.4% per signal before costs; a signal typically stayed open about 1 d.
| Buy signal | Price then | Closed | Held | Outcome |
|---|---|---|---|---|
| 22 Sep 2025 | $11.23 | 5 Jan 2026 | 15 wk | -4.2% |
| 19 Sep 2025 | $12.26 | 19 Sep 2025 | 1 d | -12.3% |
| 18 Sep 2025 | $12.14 | 18 Sep 2025 | 1 d | -10.8% |
| 17 Sep 2025 | $11.5 | 17 Sep 2025 | 1 d | -11.6% |
| 9 Sep 2025 | $11.46 | 9 Sep 2025 | 1 d | -11.0% |
| 18 Aug 2025 | $12.05 | 19 Aug 2025 | 1 d | -14.1% |
| 31 Mar 2025 | $11.4 | 9 Jun 2025 | 10 wk | -5.7% |
| 3 Mar 2025 | $10.88 | 3 Mar 2025 | 1 d | -0.5% |
| 1 Nov 2024 | $10.52 | 3 Mar 2025 | 4 mo | +3.1% |
Outcomes are simulated by applying Firefly's rules to historical prices, before costs and slippage. Sell triggers are not counted: Firefly reads them as “don't enter”, not as short trades. Past behaviour of a rule is not a prediction of future prices.
The strategy behind this page
one rule set per market · beta| Strategy | Horizon | Signal | Since | Buy signals closed higher |
|---|---|---|---|---|
| Firefly Breakout Weekly | Medium term | No signal | — | 11% |
This beta publishes one rule set per market — Firefly Breakout Weekly — chosen in the October 2026 review. What the beta shows and how the data was cleaned →
Same theme beyond US
same theme, other marketsIndian peers are listed on the NSE and priced in rupees. Crypto gains are taxed at 30% in India with 1% TDS. Shown for context — not a recommendation to switch markets.
More questions about BBOT
BBOT share price today — buy or sell?
As of 30 Sep 2026, Firefly Breakout Weekly says wait on BridgeBio Oncology Therapeutics. No open signal as of 30 Sep 2026. The last Buy signal came on 22 Sep 2025 at $11.23 and closed on 5 Jan 2026 (−4.2%). The last price on record was $10.75 on 5 Jan 2026.
How has Firefly's strategy done on BridgeBio Oncology Therapeutics?
From October 2024 to 30 Sep 2026 Firefly's rules gave 9 buy signals on BridgeBio Oncology Therapeutics; 1 closed above the entry price and the average outcome was −7.4% per signal, simulated on historical prices before costs. A handful of signals is a pattern, not a statistic.
What is the BridgeBio Oncology Therapeutics price target?
We don't publish price targets — no rule-based system can forecast a price. Firefly Breakout Weekly closes each signal by its own rules; every closed signal on BridgeBio Oncology Therapeutics and how it turned out is listed on this page.
Should I sell BridgeBio Oncology Therapeutics?
No sell trigger is active on BridgeBio Oncology Therapeutics as of 30 Sep 2026. This describes a rule, not advice on your position.
Why does this page show a single strategy?
This is the Signals beta. Each market publishes one rule set — here Firefly Breakout Weekly — instead of a vote across Firefly's whole library, and the verdict is its signal as of 30 Sep 2026. Sell triggers count as “don't enter”; only buy triggers are scored.
Fintrens shows how one of Firefly's rule-based strategies reads this stock. It is educational information, not investment advice and not a recommendation to buy or sell. We do not publish price targets. Indian residents buy US stocks under the RBI's Liberalised Remittance Scheme; tax is collected at source above the annual threshold. Read how Firefly's strategies work →